ABSTRACT Aims/Introduction: Studies have been carried out to evaluate the correlation between TCF7L2 genetic polymorphisms and gestational diabetes mellitus (GDM) risk. However, the conclusions from these studies are incomplete, because partial single nucleotide polymorphisms (SNPs) were analyzed. We carried out a meta-analysis aimed to systematically evaluate TCF7L2 gene polymorphisms and GDM susceptibility in all population and racial/ ethnic subgroups to afford a foundation for future research. Materials and Methods: Published studies censoring TCF7L2 variants and GDM risk were captured from the EMBASE, PubMed, CNKI and Wanfang databases. The meta-analysis was processed using software of RevMan 5.2 and Stata13. The relationship between TCF7L2 polymorphism and GDM occurrence was evaluated by pooled odds ratios. Stratified analysis based on race/ethnicity was also carried out. The allele-specific odds ratios and 95% confidence intervals were counted, and based on homogeneity evaluated using the I 2 -test, fixed-or random-effects pooled measures were selected. Results: A total of 22 studies were covered, capturing eight TCF7L2 SNPs and involving 5,573 cases and 13,266 controls. Six of eight SNPs showed significant relationships with GDM occurrence, of which the SNPs rs7903146, rs12255372 and rs7901695 were the most powerful. Stratified analysis by race/ethnicity showed discrepant results in these three SNPs. In Caucasians and other races, all these SNPs were found to have a significant association with GDM risk, but in Asians, only SNP rs7903146 showed a significant association. Conclusions: Six of eight SNPs were found to have significant associations between TCF7L2 variants and GDM risk in the overall population, with the most powerful in SNPs being rs7903146, rs12255372 and rs7901695, but the contribution of these SNPs to GDM risk were variable among different racial/ethnic groups.
INTRODUCTION
Gestational diabetes mellitus (GDM), defined as impaired glucose tolerance with onset or first identification during pregnancy, is one of the most frequent complications of pregnancy. The prevalence is estimated to be 5-10%, and the incidence rate has shown a gradual upward trend 1, 2 , making it a growing health issue 3 . GDM increases the risk of adverse pregnancy outcomes, and has adverse effects for both mothers and their children, including susceptibility to obesity, metabolic syndrome and type 2 diabetes mellitus in later life [3] [4] [5] . Furthermore, GDM occurrence is confused in different populations or ethnic groups. Therefore, it is necessary to systematically evaluate TCF7L2 gene polymorphisms and GDM susceptibility in all population and racial/ethnic subgroups.
GDM is a heterogeneous metabolic disorder, with mixed genetic etiology and phenotypes 6 . Insulin resistance is regarded as an important factor to contribute to GDM. Furthermore, there are heritable elements, and GDM could share some risk factors of genetics with type 2 diabetes mellitus 7 . Transcription factor 7-like 2 (TCF7L2) expresses in pancreatic b-cells 8 , and belongs to the high mobility group-box family as a transcription factor 9 that plays a crucial role in the maintenance of glucose homeostasis. Recent findings suggest that the TCF7L2 contributes to GDM risk 10 . So far, TCF7L2 has multiple single nucleotide polymorphisms (SNPs), eight of which have been reported, including rs7903146 [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] ; rs12255372 [16] [17] [18] [19] [20] [21] 26, [28] [29] [30] ; rs7901695 18, 20, 25, 29, 31 ; rs290487 28, 32, 33 ; rs11196205 28, 32 ; rs11196218 32, 34 ; rs12243326 25, 29 ; and rs4506565. 25, 29 The SNP rs7903146 has been most widely researched, and has been associated with an increased risk of GDM in Scandinavian women 7 . A study of Mexican Americans showed that SNP rs12255372 of TCF7L2 has a relationship with GDM risk and affected the insulin response to oral glucose in propends with GDM 30 , and rs7901695 has been shown to benefit individuals with type 2 diabetes mellitus and GDM risk 18 . The SNPs rs7903146 C>T, rs12255372 G>T and rs7901695 T>C are the strongest to be beneficial to GDM risk 35 , and lie within a well-defined linkage disequilibrium block [36] [37] [38] . A study has also shown that SNPs were susceptible to type 2 diabetes mellitus occurrence through damaging insulin secretion, possibly attributable to a potential mechanism in b-cells 39 . The other five SNPs have been less studied, and conflicting findings exist. Furthermore, individual studies might be limited by relatively inadequate sample sizes, and might be unable to receive convincing results. Therefore, we carried out a meta-analysis to examine the association between TCF7L2 polymorphisms and the risk of GDM.
MATERIALS AND METHODS

Literature search
A retrieve was carried out for related available articles published in four databases including PubMed and EMBASE for English articles, and China National Knowledge Infrastructure and Wanfang for Chinese articles. 'TCF7L2', 'transcription factor 7-like 2', 'polymorphism', 'SNP', 'GDM', 'gestational diabetes mellitus', 'Gestational diabetes' and 'Screening for gestational diabetes' as keywords were used to search. We also evaluated the references in the retrieved studies, and recognized extrapublished articles not captured in review articles by search strategy from these databases.
Inclusion criteria
The following was the inclusion criteria, including: (i) casecontrol or cohort study published as an original study to assess the relationship between TCF7L2 polymorphisms with GDM risk; (ii) precise numbers for each genotype reported in case and control groups or exposed and unexposed groups, or countable data from these numbers in the published papers; and (iii) participants from the same ethnicity and the same time in each research; and (iv) the nearest and integrated article was selected if a paper had been published more than once.
Data extraction
According to the inclusion criteria listed above, information was drawn from all eligible papers by two reviewers (Chang Shaoyan and Wang Zhen) independently, and the validation was tested by a third reviewer if there was disagreement. The literature were eliminated as follows: overviews or editorials, studies with cell culture or animal research, studies based on family, studies of the primary outcome exclusive of GDM, and studies with no evaluation of the relationships of GDM and TCF7L2 polymorphisms, and studies that excluded a quality control group, or insufficient data for influence evaluations of the genetic relationships. Data were drawn from each published article as follows: first author, publication year, ethnicity, country, mean age, genotyping method, size of sample, number of cases and controls, study design, genetic variants, minor allele and allele distribution by GDM situation. If odds ratios (ORs) were accessible, but the genotype and allele distributions on the basis of GDM situation were not covered in the primitive study, the corresponding authors were contacted by email.
Quality assessment
Risk of bias was devoted to evaluate the methodological reliability of the incorporated studies. Quality was accessed based on five questions, using different colors for low risk (green), unclear risk (yellow), and high risk (read), with more green manifesting better research quality. 2 was the percentage of total degree of variation observed among the studies due to actual differences between the trials rather than to sampling error (chance), where I 2 > 50% is regarded as a significant heterogeneity.
Statistical analysis
RESULTS
Description of the included studies
The search generated 147 articles of which 21 were eligible for meta-analysis ( Figure 1) . The 22 eligible studies captured eight TCF7L2 SNPs, and included 5,573 cases and 13,266 controls. There were 18 studies about rs7903146, 10 about rs12255372, 5 about rs7901695, 3 about rs290487, 2 about rs11196205, 2 Tables 1 and 2 .
Meta-analysis results
The SNP rs7903146 of TCF7L2 was the most extensively studied variant, and showed a conflicting correlation across different populations. The results of the allele distribution are described Figure 3 ).
Additionally, a significant relationship was discovered between the C allele of SNP rs7901695 and GDM risk by meta-analysis with 1 Three variants in the TCF7L2 gene, including rs290487, rs11196205 and rs11196218, were researched only in Chinese populations (Figures 5-7 ). There was a significant correlation between rs290487 (FEM, OR 1.25, 95% CI: 1.08-1.46) and GDM risk, but no correlation with rs11196205 (FEM, OR 1.24, 95% CI: 0.71-2.18) and rs11196218 (FEM, OR 1.06, 95% CI: 0.90-1.26). Two other SNPs in the TCF7L2 gene were found only in two literature research articles with different ethnicity, and they had significant correlations between rs4506565 (FEM, OR 1.72, 95% CI: 1.33-2.23) with GDM, and rs12243326 (FEM, OR 1.76, 95% CI: 1.32-2.34) with GDM (Figures 8 and 9 ).
Heterogeneity
Heterogeneity between studies was measured in all comparisons. There was no heterogeneity in rs7901695, rs4506565 and rs290487 with I 2 = 0%, slight heterogeneity in rs11196205 (I 2 = 34%), rs11196218 (I 2 = 10%) and rs12243326 (I 2 = 27%), but severe heterogeneity in rs12255372 (I 2 = 67%) and rs7903146 (I 2 = 77%). Except for rs12255372 and rs7903146, all SNPs in the TCF7L2 gene were analyzed using the FEM. Although subgroup analysis according to ethnicity of rs12255372 and rs7903146 was carried out, heterogeneity was still severe. Therefore, the use of REMs was justified in these analyses.
Publication bias analysis
Publication bias of all TCF7L2 SNPs was determined using a funnel plot of Revman 5.2, but vague results of SNPs rs7903146 and SNPs rs7903146 were found. Therefore, Egger of Stata13 was used to further confirm the results. The results showed that no evidence of statistically significant publication bias was detected for the studies (Figure S1-S8 ; Tables S1-S4) .
DISCUSSION
An increasing number of studies have shown that TCF7L2 variants are related to GDM risk. However, the results of the studies are inconsistent and incomplete, and might have limited statistical power with individual studies having relatively small sample sizes and the analysis of partial SNPs. Therefore, we carried out the meta-analysis with the aim to provide a more comprehensive summary of the currently available evidence with respect to the relationship between TCF7L2 variants and GDM risk. Total events 1,707 999 Heterogeneity: τ 2 = 2.11, df = 5 (P = 0.83); I 2 = 0% Test for overall effect: Z = 7.53 (P < 0.00001) Test for subgroup differences: χ 2 = 0.06. df = 1 (P = 0.81); I 2 = 0% Total events 555 519 Heterogeneity: χ 2 = 0.00, df = 2 (P = 1.00); I 2 = 0% Test for overall effect: Z = 2.92 (P = 0.004) 1. C>T, rs12255372 G>T and rs7901695 T>C were the most powerful to assess the relationship between TCF7L2 polymorphism and the risk of GDM. The SNPs rs7903146 and rs7901695 showed significant relationships with GDM risk in the overall and subgroup analyses; however, the relationship of rs12255372 was significant and conflicting among different ethnicities. GDM can progress when a genetic susceptibility to pancreatic islet b-cell injury is exposed by incremental insulin resistance during pregnancy 40 . Among the most widely studied genes involved in GDM risk, TCF7L2 is identified as regulating b-cell action 41 . It is well known that TCF7L2 expresses in pancreatic b-cells, and belongs to the supernal mobility group-box transcription factors family and plays a vital role in maintaining glucose homeostasis. Eight SNPs in the TCF7L2 gene have been reported, including rs7903146, rs12255372, rs7901695, rs290487, rs4506565, rs11196205, rs11196218 and rs12243326.
The most widely studied SNP was rs7903146, and a previous meta-analysis regarding this SNP found a 1.65-fold increased risk of GDM, based on six studies 42 , and 1.63-fold in 16 studies 43 . We identified 18 studies assessing the association, and the results were consistent with the previous analysis. Furthermore, we carried out subgroup analysis based on ethnicity, and found a significant correlation in Caucasian and Asian ethnicities and others, as seen in the previous study. Combined with all results, T allele of the SNP rs7903146 of TCF7L2 was related to GDM risk.
The rs12255372 variant was also widely studied with the results of different relationships with GDM risk in different populations. A systematic review of four studies found a significant relationship between this SNP and GDM 44 . We extended the sample to nine studies, and increased the number of participants to carry out a relatively comprehensive assessment. The significant relationship remained, with rs12255372 associated with GDM, consistent with previous research. However, findings of the subgroup analysis differed, with a significant correlation in Caucasian and other groups, but no association in Asian groups. Overall, this suggests that the T allele of rs12255372 might be related to GDM risk, but to varying degrees among different ethnicities.
A significant relationship was discovered in the meta-analysis regarding the C allele of rs7901695 and the risk of GDM (OR 1.49, 95% CI: 1.34-1.66), with subgroup analysis showing a significant correlation in Caucasian, Asian and other groups.
In conclusion, different relationships between TCF7L2 variants and GDM risk among different ethnic groups might be attributable to genetic characteristics and sample size, or selection standards of participants, but could also be because of different growth environments, body structure and variations in genetic background. Therefore, ongoing research and systematic analysis is important. Because we were unable to completely eliminate potential bias and heterogeneous factors in the present meta-analysis, further studies with rich sample capacity and using normalized unbiased genotyping methods are required to verify the present findings. Figure S1 | Funnel plots of publication bias for the relationship of TCF7L2 rs7903146 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S2 | Funnel plots of publication bias for the relationship of TCF7L2 rs12255372 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S3 | Funnel plots of publication bias for the relationship of TCF7L2 rs7901695 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S4 | Funnel plots of publication bias for the relationship of TCF7L2 rs290487 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S5 | Funnel plots of publication bias for the relationship of TCF7L2 rs4506565 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S6 | Funnel plots of publication bias for the relationship of TCF7L2 rs11196205 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S7 | Funnel plots of publication bias for the relationship of TCF7L2 rs11196218 polymorphism and risk of gestational diabetes mellitus across different populations. Figure S8 | Funnel plots of publication bias for the relationship of TCF7L2 rs12243326 polymorphism and risk of gestational diabetes mellitus across different populations. Table S1 | Publication bias list for the relationship of TCF7L2 rs7903146 polymorphism and risk of GDM across different populations. Table S2 | Egger's test of publication bias for the relationship of TCF7L2 rs7903146 polymorphism and risk of GDM across different populations. 
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